Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics

被引：0
|
作者：
Yun, Jiwon [1 ]
Kim, Jung-Ah [2 ]
Hwang, Byungjin [3 ]
Park, Hee Sue [4 ]
Im, Kyongok [5 ,6 ]
Kim, Sung-Min [7 ]
Jeong, Dajeong [1 ]
Lim, Kyu Min [7 ]
Bang, Duhee [3 ]
Lee, Dong Soon [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[2] Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea
[4] Chungbuk Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[5] Inst Reprod Med, Seoul, South Korea
[6] Populat Med Res Ctr, Seoul, South Korea
[7] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
来源：
BLOOD | 2018年 / 132卷
关键词：
Myeloproliferative neoplasms; next-generation sequencing; triple negative MPN; chromosome; FISH; telomere;
D O I：
10.1182/blood-2018-99-118013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Acquired Resistance to JAK Inhibitors in Calr-Mutated Myeloproliferative Neoplasms
    Lim, Ken-Hong
    Chang, Yu-Cheng
    Chiang, Yi-Hao
    Lin, Huan-Chau
    Huang, Ling
    Wang, Wei-Ting
    Su, Ying-Wen
    Chang, Ming-Chih
    Chang, Yi-Fang
    Chen, Caleb Gon-Shen
    BLOOD, 2019, 134
  • [32] JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms
    Wong, Waihay J.
    Hasserjian, Robert P.
    Pinkus, Geraldine S.
    Breyfogle, Lawrence J.
    Mullally, Ann
    Pozdnyakova, Olga
    HAEMATOLOGICA, 2018, 103 (02) : E63 - E68
  • [33] Molecular insights into regulation of JAK2 in myeloproliferative neoplasms
    Silvennoinen, Olli
    Hubbard, Stevan R.
    BLOOD, 2015, 125 (22) : 3388 - 3392
  • [34] Molecular Profiles and Clinical Features of Myeloproliferative Neoplasms Unclassifiable (MPN-U) with and without JAK2/CALR/MPL Mutations
    Gravenmier, Curtis
    Zhang, Yumeng
    Pakasticali, Nagehan
    Moscinski, Lynn C.
    Song, Jinming
    Zhang, Ling
    BLOOD, 2022, 140 : 12248 - 12249
  • [35] JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms
    Siemiatkowska, Anna
    Bieniaszewska, Maria
    Hellmann, Andrzej
    Limon, Janusz
    LEUKEMIA RESEARCH, 2010, 34 (03) : 387 - 389
  • [36] MPL Mutation Profile in JAK2 Mutation-Negative Patients with Myeloproliferative Neoplasms.
    Ma, Wanlong
    Zhang, Xi
    Wang, Xiuqiang
    Zhang, Zhong
    Yeh, Chen-Hsiung
    Sferruzza, Anthony
    Uyeji, Jennifer
    Albitar, Maher
    BLOOD, 2009, 114 (22) : 751 - 751
  • [37] Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms
    Costa Melo Svidnicki, Maria Carolina
    Campos, Paula De Melo
    Ferreira Filho, Moises Alves
    Leme Fujiura, Caio Augusto
    Yoshizato, Tetsuichi
    Makishima, Hideki
    Ogawa, Seishi
    Olalla Saad, Sara T.
    BLOOD, 2019, 134
  • [38] Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms
    Wojtaszewska, Marzena
    Iwola, Malgorzata
    Lewandowski, Krzysztof
    ACTA HAEMATOLOGICA, 2015, 133 (02) : 193 - 198
  • [39] Calr Gene Mutation in Patients with JAK2-Negative Myeloproliferative Neoplasms
    Xu Jingyan
    Zhou, Rong-Fu
    Chen, Bing
    Ouyang, Jian
    BLOOD, 2014, 124 (21)
  • [40] MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F
    Culurgioni, F.
    Musiu, C.
    Uda, S.
    Benziane, A.
    Pettinau, M.
    Usala, E.
    Cabras, M. G.
    HAEMATOLOGICA, 2017, 102 : 167 - 168
12345